$0.04
0.00 (+9.38%)
deCODE genetics, Inc. (DCGN)
CAPS Rating:
A biopharmaceutical company applying its discoveries in human genetics to develop drugs and diagnostics for common diseases.
A biopharmaceutical company applying its discoveries in human genetics to develop drugs and diagnostics for common diseases.